Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Pharmacother ; 101: 30-36, 2018 May.
Article in English | MEDLINE | ID: mdl-29477055

ABSTRACT

Diabetes Mellitus (DM) is associated with an increased susceptibility to various infections, which might be attributed to changes in immune response owing to chronic hyperglycemia. Nucleoside triphosphate diphosphohydrolase (NTPDase), 5'-nucleotidase, and adenosine deaminase (ADA) are important enzymes involved in the generation of anti-aggregant and anti-inflammatory microenvironments. The aim of this study was to evaluate the effect of gallic acid (GA) on the hematological parameters and ectonucleotidase activities in platelets, lymphocytes, and serum of diabetic rats. Experimental rats were categorized into 4 groups: (i) control -saline, (ii) control - GA, (iii) diabetic -saline, and (iv) diabetic - GA. One week after induction of DM using streptozotocin (65 mg/kg), GA (30 mg/kg) or saline was orally administered to the rats for 21 days. Our results demonstrated that the concentration of mean corpuscular hemoglobin was decreased, whereas that of red cell distribution was increased in the diabetic group, however, GA could revert these alterations. Moreover, in diabetic rats, GA reverted the increase in ATP and ADP hydrolysis and ADA activity in lymphocytes, and it prevented the increase in NTPDase and ADA activities in platelets. A decrease in ATP hydrolysis and an increase in ADP and AMP hydrolysis were observed in the serum of diabetic rats; however, GA treatment could solely revert changes in ATP hydrolysis. Our study suggests that GA exhibits beneficial effects on immuno- and thrombo-regulatory responses in DM and that these effects may be related to the modulation of purinergic signaling.


Subject(s)
Blood Platelets/metabolism , Diabetes Mellitus, Experimental/blood , Gallic Acid/pharmacology , Lymphocytes/metabolism , Purine Nucleotides/metabolism , Serum/metabolism , Animals , Blood Platelets/drug effects , Diabetes Mellitus, Experimental/drug therapy , Gallic Acid/therapeutic use , Lymphocytes/drug effects , Male , Platelet Aggregation/drug effects , Platelet Aggregation/physiology , Purine Nucleotides/agonists , Purine Nucleotides/antagonists & inhibitors , Rats , Rats, Wistar , Serum/drug effects , Signal Transduction/drug effects , Signal Transduction/physiology
2.
Biomed Pharmacother ; 84: 1291-1299, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27810786

ABSTRACT

Diabetes mellitus (DM) is characterised by hyperglycaemia associated with the increase of oxidative stress. Gallic acid has potent antioxidant properties. The aim of this study was to evaluate the effect of gallic acid on the biochemical, histological and oxidative stress parameters in the liver and kidney of diabetic rats. Male rats were divided in groups: control, gallic acid, diabetic and diabetic plus gallic acid. DM was induced in the animals by intraperitoneal injection of streptozotocin (65mg/kg). Gallic acid (30mg/kg) was administered orally for 21days. Our results showed an increase in reactive species levels and lipid peroxidation, and a decrease in activity of the enzymes superoxide dismutase and delta-aminolevulinic acid dehydratase in the liver and kidney of the diabetic animals (P<0.05). Gallic acid treatment showed protective effects in these parameters evaluated, and also prevented a decrease in the activity of catalase and glutathione S-transferase, and vitamin C levels in the liver of diabetic rats. In addition, gallic acid reduced the number of nuclei and increased the area of the core in hepatic tissue, and increased the glomerular area in renal tissue. These results indicate that gallic acid can protect against oxidative stress-induced damage in the diabetic state.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Experimental/enzymology , Gallic Acid/therapeutic use , Kidney/pathology , Liver/pathology , Oxidative Stress , Porphobilinogen Synthase/metabolism , Animals , Blood Glucose/metabolism , Body Weight/drug effects , Catalase/metabolism , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/pathology , Gallic Acid/chemistry , Gallic Acid/pharmacology , Glutathione Transferase/metabolism , Hepatocytes/drug effects , Hepatocytes/pathology , Kidney/drug effects , Kidney/enzymology , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Male , Oxidative Stress/drug effects , Rats, Wistar , Reactive Oxygen Species/metabolism , Streptozocin , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
3.
Phytother Res ; 30(7): 1156-63, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27151061

ABSTRACT

Hypertension is associated with platelet alterations that could contribute to the development of cardiovascular complications. Several studies have reported antiplatelet aggregation properties of ginger (Zingiber officinale) and turmeric (Curcuma longa) with limited scientific basis. Hence, this study assessed the effect of dietary supplementation of these rhizomes on platelet ectonucleotidase and adenosine deaminase (ADA) activities in Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME) induced hypertensive rats. Animals were divided into seven groups (n = 10): normotensive control rats; induced (l-NAME hypertensive) rats; hypertensive rats treated with atenolol (10 mg/kg/day); normotensive and hypertensive rats treated with 4% supplementation of turmeric or ginger, respectively. After 14 days of pre-treatment, the animals were induced with hypertension by oral administration of l-NAME (40 mg/kg/day). The results revealed a significant (p < 0.05) increase in platelet ADA activity and ATP hydrolysis with a concomitant decrease in ADP and AMP hydrolysis of l-NAME hypertensive rats when compared with the control. However, dietary supplementation with turmeric or ginger efficiently prevented these alterations by modulating the hydrolysis of ATP, ADP and AMP with a concomitant decrease in ADA activity. Thus, these activities could suggest some possible mechanism of the rhizomes against hypertension-derived complications associated to platelet hyperactivity. Copyright © 2016 John Wiley & Sons, Ltd.


Subject(s)
Adenosine Deaminase/metabolism , Adenosine Triphosphatases/metabolism , Blood Platelets/drug effects , Curcuma , Dietary Supplements , Hypertension/drug therapy , Zingiber officinale , Animals , Blood Platelets/enzymology , Blood Pressure/drug effects , Hypertension/enzymology , Male , NG-Nitroarginine Methyl Ester/pharmacology , Phytotherapy , Rats , Rats, Wistar , Rhizome
4.
Biomarkers ; 21(6): 530-7, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27075266

ABSTRACT

CONTEXT: This study aims to explore the potential of new inflammatory markers for improving the challenging diagnosis of acute appendicitis (AA). METHODS: Levels of IL-1, IL-6, IL-8, IL-10, CRP, INF-γ, and TNF-α in serum were measured in 73 patients with AA. Oxidative stress and antioxidant enzymes were analyzed. RESULTS: Serum levels of interleukins, TNF-α, and INF-γ were significantly elevated in patients with appendicitis (p < 0.0001), except for IL-10, which presented decreased levels. There were no significant differences in SOD (p = 0.29), CAT (p = 0.19), or TBARS levels (p = 0.18), whereas protein carbonyls presented significant increase (p < 0.0001). CONCLUSION: Evaluating these biomarkers could aid in diagnosing AA.


Subject(s)
Appendicitis/blood , Cytokines/blood , Oxidative Stress , Adolescent , Adult , Aged , Appendicitis/diagnosis , Biomarkers/blood , Case-Control Studies , Catalase/blood , Female , Humans , Male , Middle Aged , Superoxide Dismutase/blood , Young Adult
5.
Planta Med ; 82(7): 612-20, 2016 May.
Article in English | MEDLINE | ID: mdl-27002391

ABSTRACT

Inflammation exerts a crucial pathogenic role in the development of hypertension. Hence, the aim of the present study was to investigate the effects of ginger (Zingiber officinale) and turmeric (Curcuma longa) on enzyme activities of purinergic and cholinergic systems as well as inflammatory cytokine levels in Nω-nitro-L-arginine methyl ester hydrochloride-induced hypertensive rats. The rats were divided into seven groups (n = 10); groups 1-3 included normotensive control rats, hypertensive (Nω-nitro-L-arginine methyl ester hydrochloride) rats, and hypertensive control rats treated with atenolol (an antihypertensive drug), while groups 4 and 5 included normotensive and hypertensive (Nω-nitro-L-arginine methyl ester hydrochloride) rats treated with 4 % supplementation of turmeric, respectively, and groups 6 and 7 included normotensive and hypertensive rats treated with 4 % supplementation of ginger, respectively. The animals were induced with hypertension by oral administration of Nω-nitro-L-arginine methyl ester hydrochloride, 40 mg/kg body weight. The results revealed a significant increase in ATP and ADP hydrolysis, adenosine deaminase, and acetylcholinesterase activities in lymphocytes from Nω-nitro-L-arginine methyl ester hydrochloride hypertensive rats when compared with the control rats. In addition, an increase in serum butyrylcholinesterase activity and proinflammatory cytokines (interleukin-1 and - 6, interferon-γ, and tumor necrosis factor-α) with a concomitant decrease in anti-inflammatory cytokines (interleukin-10) was observed in Nω-nitro-L-arginine methyl ester hydrochloride hypertensive rats. However, dietary supplementation of both rhizomes was efficient in preventing these alterations in hypertensive rats by decreasing ATP hydrolysis, acetylcholinesterase, and butyrylcholinesterase activities and proinflammatory cytokines in hypertensive rats. Thus, these activities could suggest a possible insight about the protective mechanisms of the rhizomes against hypertension-related inflammation.


Subject(s)
Acetylcholinesterase/metabolism , Butyrylcholinesterase/metabolism , Curcuma , Cytokines/metabolism , Hypertension/diet therapy , Plant Preparations/therapeutic use , Zingiber officinale , Animals , Cholinergic Agents/isolation & purification , Cholinergic Agents/pharmacology , Hypertension/enzymology , Male , Purinergic Agents/isolation & purification , Purinergic Agents/pharmacology , Rats , Rats, Wistar , Rhizome , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism
6.
J Physiol Biochem ; 71(4): 743-51, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26452500

ABSTRACT

In the present study, we investigated the efficiency of rosmarinic acid (RA) in preventing the alteration of oxidative parameters in the liver and kidney of diabetic rats induced by streptozotocin (STZ). The animals were divided into six groups (n = 8): control, ethanol, RA 10 mg/kg, diabetic, diabetic/ethanol, and diabetic/RA 10 mg/kg. After 3 weeks of treatment, we found that TBARS levels in liver and kidney were significantly increased in the diabetic/saline group and the administration of RA prevented this increase in the liver and kidney (P < 0.05). Diabetes caused a significant decrease in the activity of superoxide dismutase (SOD) and catalase (CAT) in the diabetes/saline group (P < 0.05). However, the treatment with 10 mg/kg RA (antioxidant) prevented this alteration in SOD and CAT activity in the diabetic RA group (P < 0.05). In addition, RA reverses the decrease in ascorbic acid and non-protein-thiol (NPSH) levels in diabetic rats. The treatment with RA also prevented the decrease in the Delta-aminolevulinic acid dehydratase (ALA-D) activity in the liver and kidney of diabetic rats. Furthermore, RA did not have any effect on glycemic levels. These results indicate that RA effectively reduced the oxidative stress induced by STZ, suggesting that RA is a potential candidate for the prevention and treatment of pathological conditions in diabetic models.


Subject(s)
Antioxidants/pharmacology , Cinnamates/pharmacology , Depsides/pharmacology , Diabetes Mellitus, Experimental/drug therapy , Kidney/metabolism , Liver/metabolism , Animals , Antioxidants/therapeutic use , Ascorbic Acid/metabolism , Biomarkers/metabolism , Blood Glucose , Cinnamates/therapeutic use , Depsides/therapeutic use , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Drug Evaluation, Preclinical , Kidney/drug effects , Liver/drug effects , Male , Malondialdehyde/metabolism , Oxidative Stress , Rats, Wistar , Streptozocin , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism , Rosmarinic Acid
7.
Mol Cell Biochem ; 396(1-2): 201-11, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25064450

ABSTRACT

The ex vivo and in vitro effects of quercetin on NTPDase, adenosine deaminase (ADA), and acetycholinesterase (AChE) activities in lymphocytes, as well as the effects of quercetin on butyrylcholinesterase (BChE) activity in serum and myeloperoxidase (MPO) activity in plasma were determined in rats. For the ex vivo experiment, animals were orally exposed to Cadmium (Cd) for 45 days. Animals were divided into eight groups: saline/ethanol, saline/Querc 5 mg/kg, saline/Querc 25 mg/kg, saline/Querc 50 mg/kg, Cd/ethanol, Cd/Querc 5 mg/kg, Cd/Querc 25 mg/kg, and Cd/Querc 50 mg/kg. The ex vivo data showed an increase in the ATP and ADP hydrolysis and ADA activity in Cd-exposed rats when compared to the control group. The treatment with quercetin 25 and 50 mg/kg prevented this increase in the ATP and ADP hydrolysis, while the treatment with quercetin 5, 25, and 50 mg/kg prevented the increase in the ADA activity. AChE, BChE, and MPO activities ex vivo presented an increase in the Cd-exposed group when compared to the control group, and the treatment with quercetin 5, 25, and 50 mg/kg prevented this increase caused by Cd exposure. The in vitro experiment showed that quercetin 5, 10, 25, or 50 µM decreased the ADA activity proportionally to the increase of the concentrations of quercetin when compared to the control group. Thus, we can suggest that the quercetin is able to modulate NTPDase, ADA, AChE, and MPO activities and contribute to maintain the levels of ATP, adenosine, and acetylcholine normal, respectively, exhibiting potent pro-inflammatory and anti-inflammatory actions.


Subject(s)
Cadmium/toxicity , Cholinesterases/metabolism , Lymphocytes/drug effects , Peroxidase/metabolism , Quercetin/pharmacology , Acetylcholinesterase/metabolism , Adenosine Deaminase/metabolism , Animals , Butyrylcholinesterase/blood , Dose-Response Relationship, Drug , Hydrolysis , Lymphocytes/metabolism , Male , Protective Agents/pharmacology , Pyrophosphatases/metabolism , Rats, Wistar , Toxicity Tests/methods
8.
Cell Biochem Funct ; 32(6): 502-10, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24947461

ABSTRACT

Diabetes is associated with long-term complications in the brain and reduced cognitive ability. Vitamin D3 (VD3 ) appears to be involved in the amelioration of hyperglycaemia in streptozotocin (STZ)-induced diabetic rats. Our aim was to analyse the potential of VD3 in avoiding brain damage through evaluation of acetylcholinesterase (AChE), Na(+) K(+) -adenosine triphosphatase (ATPase) and delta aminolevulinate dehydratase (δ-ALA-D) activities and thiobarbituric acid reactive substance (TBARS) levels from cerebral cortex, as well as memory in STZ-induced diabetic rats. Animals were divided into eight groups (n = 5): control/saline, control/metformin (Metf), control/VD3 , control/Metf + VD3 , diabetic/saline, diabetic/Metf, diabetic/VD3 and diabetic/Metf + VD3 . Thirty days after treatment, animals were submitted to contextual fear-conditioning and open-field behavioural tests, after which they were sacrificed and the cerebral cortex was dissected. Our results demonstrate a significant memory deficit, an increase in AChE activity and TBARS levels and a decrease in δ-ALA-D and Na(+) K(+) -ATPase activities in diabetic rats when compared with the controls. Treatment of diabetic rats with Metf and VD3 prevented the increase in AChE activity when compared with the diabetic/saline group. In treated diabetic rats, the decrease in Na(+) K(+) -ATPase was reverted when compared with non-treated rats, but the increase in δ-ALA-D activity was not. VD3 prevented diabetes-induced TBARS level and improved memory. Our results show that VD3 can avoid cognitive deficit through prevention of changes in important enzymes such as Na(+) K(+) -ATPase and AChE in cerebral cortex in type 1 diabetic rats.


Subject(s)
Cholecalciferol/pharmacology , Diabetes Mellitus, Type 1/drug therapy , Vitamins/pharmacology , Acetylcholinesterase/metabolism , Animals , Blood Glucose/drug effects , Body Weight/drug effects , Cerebral Cortex/drug effects , Cholecalciferol/therapeutic use , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/metabolism , Diabetes Mellitus, Type 1/psychology , Eating/drug effects , Fear/drug effects , Hypoglycemic Agents/pharmacology , Male , Memory/drug effects , Metformin/pharmacology , Porphobilinogen Synthase/metabolism , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism , Streptozocin , Thiobarbituric Acid Reactive Substances/metabolism , Vitamins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...